Many patients modifying medication dosage forms without professional advice
the ONA take:
According to a new study published in the Journal of Pharmacy Practice and Research, researchers from Queensland University of Technology and the University of Queensland in Queensland, Australia, have found that people who take more than four doses of medication each day are more likely to crush tablets or open capsules, thereby possibly decreasing their effectiveness.
Results of the study showed that 44.2% of the 369 respondents believed there would be no issues with crushing tablets or opening capsules.
Researchers also found that 14% said they have trouble swallowing capsules or tablets and that people modified their medicine despite no issues with swallowing. In addition, 10% of respondents reported modifying their medication regardless of how many doses they took each day.
Although the findings found that many participants said they would not ask for advice before modifying their medications or inform their healthcare professional of problems swallowing, previous research has found that healthcare professionals are not asking their patients about swallowing difficulties often enough.
People who take more than four doses of medication each day are more likely to crush tablets or open capsules.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- The Integration of Cannabis in Oncologic Care
- CTCs Promising as Biomarker to Identify Lung Cancer Recurrence
- Hypofractionated RT, Conventional RT Comparable in Intermediate-Risk Prostate Cancer
- Social Functioning Scores for Young Cancer Survivors Remain Lower Than Their Peers
- Mortality Rates Highest Among Youngest Oncology Patients, Particularly Minorities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|